A CONTROLLED TRIAL OF COSALDON IN ARTERIOSCLEROTIC DEMENTIA.
D001161:Arteriosclerosis; D035843:Biomedical Research; D002561:Cerebrovascular Disorders; D003704:Dementia; D015140:Dementia, Vascular; D004338:Drug Combinations; D005853:Geriatrics; D006801:Humans; D001523:Mental Disorders; D009539:Nicotinic Acids; D010243:Paralysis; D011618:Psychotic Disorders; D012171:Retinal Vessels; D013805:Theobromine / Q000031:analogs & derivatives; D014116:Toxicology; D014665:Vasodilator Agents
D004338:Drug Combinations; D009539:Nicotinic Acids; D014665:Vasodilator Agents; C007138:nicotinic acid, pentifylline drug combination; D013805:Theobromine
ARTERIOSCLEROSIS; CEREBROVASCULAR DISORDERS; CLINICAL RESEARCH; GERIATRICS; PARALYSIS; PSYCHOSES, SENILE; RETINAL VESSELS; TOXICOLOGIC REPORT; VASODILATOR AGENTS